{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T17:24:48Z","timestamp":1748539488720},"reference-count":35,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"no fund"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Orbit"],"published-print":{"date-parts":[[2022,7,4]]},"DOI":"10.1080\/01676830.2021.1929338","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T05:24:17Z","timestamp":1621920257000},"page":"437-446","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Disease modifying drugs in idiopathic sclerosing orbital inflammatory syndrome"],"prefix":"10.1080","volume":"41","author":[{"given":"Farzad","family":"Pakdel","sequence":"first","affiliation":[{"name":"Department of Oculo-facial Plastic Surgery, Farabi Hospital, Eye Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anousheh","family":"Haghighi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloofar","family":"Pirmarzdashti","sequence":"additional","affiliation":[{"name":"Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"e_1_3_4_2_1","first-page":"581","article-title":"Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis","volume":"6","author":"McCarthy JM","year":"1993","unstructured":"McCarthy JM, White VA, Harris G, Simons KB, Kennerdell J, Rootman J. Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis. Mod Pathol. 1993;6:581\u2013587.","journal-title":"Mod Pathol"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.124.9.1244"},{"issue":"10","key":"e_1_3_4_4_1","first-page":"758","article-title":"Bilateral idiopathic sclerosing inflammation of the orbit: report of three cases","volume":"27","author":"Liu CH","year":"2004","unstructured":"Liu CH, Ma L, Ku WJ, Kao LY, Tsai YJ. Bilateral idiopathic sclerosing inflammation of the orbit: report of three cases. Chang Gung Med J. 2004; 27(10):758\u2013765.","journal-title":"Chang Gung Med J"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3282bfe85b"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.1581"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.18.7.723"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-015-0232-5"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206616"},{"key":"e_1_3_4_10_1","unstructured":"FDA. Therapeutic biological products approvals. [Online]. https:\/\/wayback.archive-it.org\/7993\/20170112025945\/http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/HowDrugsareDevelopedandApproved\/ApprovalApplications\/TherapeuticBiologicApplications\/ucm080402.htm. Accessed March 4 2019."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12883"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26354"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0317-8"},{"key":"e_1_3_4_14_1","unstructured":"Seo P. October 24 2017. Uptodate: overview of immunosuppressive and conventional (non-biologic) disease-modifying drugs in the rheumatic diseases. [Online]. https:\/\/www.uptodate.com\/contents\/overview-of-immunosuppressive-and-conventional-non-biologic-disease-modifying-drugs-in-the-rheumatic-diseases. Accessed March 3 2019."},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-200604620-00014"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.328"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2015.06.004"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.06.077"},{"key":"e_1_3_4_19_1","first-page":"1374","article-title":"Treatment of orbital myositis with adalimumab (Humira)","volume":"32","author":"Adams AB","year":"2005","unstructured":"Adams AB, Kazim M, Lehman TJ. Treatment of orbital myositis with adalimumab (Humira). J Rheumatol. 2005;32:1374\u20131375.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(94)31298-X"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e318238ecf7"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iop.0000231549.24125.7a"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31823d2103"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2008.01320.x"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-1040-8"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.06.060"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0936-6555(05)80017-2"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0606402"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.150961"},{"key":"e_1_3_4_30_1","first-page":"1623847","article-title":"Adalimumab accounts for long-term control of noninfectious uveitis also in the absence of concomitant DMARD treatment: a multicenter retrospective study","volume":"10","author":"Bitossi A","year":"2019","unstructured":"Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, et al. Adalimumab accounts for long-term control of noninfectious uveitis also in the absence of concomitant DMARD treatment: a multicenter retrospective study. Mediators Inflamm. 2019;10:1623847.","journal-title":"Mediators Inflamm"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202545"},{"key":"e_1_3_4_32_1","first-page":"7","article-title":"Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins","volume":"17","author":"Benucci M","year":"2015","unstructured":"Benucci M, Li Gobbi F, Meacci F, Mackay F, Mariette X, Marcelli C. Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins. Biologics. 2015;17:7\u201312.","journal-title":"Biologics"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-59"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305528"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090060129037"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.8179"}],"container-title":["Orbit"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01676830.2021.1929338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T19:52:16Z","timestamp":1702583536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01676830.2021.1929338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7,4]]}},"alternative-id":["10.1080\/01676830.2021.1929338"],"URL":"https:\/\/doi.org\/10.1080\/01676830.2021.1929338","relation":{},"ISSN":["0167-6830","1744-5108"],"issn-type":[{"value":"0167-6830","type":"print"},{"value":"1744-5108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iorb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iorb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}